Company intelligence / Profile preview
Qyuns Therapeutics Co., Ltd.
Taizhou, Jiangsu, Chinaqyuns.net ↗
- Ownership
- Private
- Development stage
- Commercial
01
Overview
Qyuns Therapeutics has 1 product approved by NMPA, 2 products in Phase III clinical trials, and 4 products in Phase I or Phase II trials, covering four major disease areas: skin, respiratory, digestive, and rheumatism[5].
- Therapeutic areas
- PulmonologyImmunologyDermatologyRheumatologyGastroenterology
- Modalities
- Monoclonal antibodies (mAbs)Biologic therapies
- Industry
- Biotech
02
Drug pipeline
14 assets13 more assets in the full pipeline.
03
Partnerships
Huadong MedicineCaldera Therapeutics
Beyond the preview
Go deeper on Qyuns Therapeutics Co., Ltd..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Qyuns Therapeutics Co., Ltd..